Research article: Combination PPARγ and RXR agonist treatment in melanoma cells: Functional importance of S100A2

PPAR Research

Volumn , Issue , 2010, Pages

  Klopper, Joshua P ^a,b   Sharma, Vibha ^a   Bissonnette, Reid ^c   Haugen, Bryan R ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROTEIN S 100; PROTEIN S100A2; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; MELANOMA; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

EID: 83255164688     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/729876     Document Type: Article

References (24)

1. C. Garbe and T. K. Eigentler, "Diagnosis and treatment of cutaneous melanoma: state of the art 2006, " Melanoma Research, vol. 17, no. 2, pp. 117-127, 2007. (Pubitemid 46673905)
2. G. D. Shah and P. B. Chapman, "Adjuvant therapy of melanoma, " Cancer Journal, vol. 13, no. 3, pp. 217-222, 2007.
3. P. Lorigan, T. Eisen, and A. Hauschild, "Systemic therapy for metastatic malignant melanoma-from deeply disappointing to bright future?" Experimental Dermatology, vol. 17, no. 5, pp. 383-394, 2008. (Pubitemid 351513952)
4. A. Y. Bedikian, M. M. Johnson, C. L. Warneke, et al., "Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma, " Cancer Investigation, vol. 26, no. 6, pp. 624-633, 2008. (Pubitemid 351918588)
5. J. P. Klopper, W. R. Hays, V. Sharma, M. A. Baumbusch, J. M. Hershman, and B. R. Haugen, "Retinoid X receptor-γ and peroxisome proliferator-activated receptor-γ expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment, " Molecular Cancer Therapeutics, vol. 3, no. 8, pp. 1011-1120, 2004. (Pubitemid 39199596)
6. J. P. Klopper, A. Berenz, W. R. Hays, et al., "In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma, " Clinical Cancer Research, vol. 14, no. 2, pp. 589-596, 2008. (Pubitemid 351226129)
7. R. E. Schweppe, J. P. Klopper, C. Korch, et al., "Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification, " Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, pp. 4331-4341, 2008. (Pubitemid 352789529)
8. J. P. Klopper, V. Sharma, A. Berenz, et al., "Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression, " Molecular Cancer, vol. 8, article 16, 2009.
9. D. Nonaka, L. Chiriboga, and B. P. Rubin, "Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors, " Journal of Cutaneous Pathology, vol. 35, no. 11, pp. 1014-1019, 2008.
10. S. Foser, I. Redwanz, M. Ebeling, C. W. Heizmann, and U. Certa, "Interferon-alpha and transforming growth factor-β co-induce growth inhibition of human tumor cells, " Cellular and Molecular Life Sciences, vol. 63, no. 19-20, pp. 2387-2396, 2006. (Pubitemid 44653048)
11. B. R. Haugen, L. L. Larson, U. Pugazhenthi, et al., "Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids, " Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 272-280, 2004. (Pubitemid 38183893)
12. A. Muelleri, B. W. Schäfer, S. Ferrari, et al., "The Calciumbinding protein S100A2 interacts with p53 and modulates its transcriptional activity, " Journal of Biological Chemistry, vol. 280, no. 32, pp. 29186-29193, 2005. (Pubitemid 41161370)
13. I. Salama, P. S. Malone, F. Mihaimeed, and J. L. Jones, "A review of the S100 proteins in cancer, " European Journal of Surgical Oncology, vol. 34, no. 4, pp. 357-364, 2008. (Pubitemid 351381290)
14. M. Grigorian, S. Andresen, E. Tulchinsky, et al., "Tumor suppressor p53 protein is a new target for the metastasisassociated Mts1/S100A4 protein: functional consequences of their interaction, " Journal of Biological Chemistry, vol. 276, no. 25, pp. 22699-22708, 2001.
15. H. Wang, Z. Zhang, R. Li, et al., "Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer, " International Journal of Cancer, vol. 116, no. 2, pp. 285-290, 2005. (Pubitemid 40967267)
16. B. Bartling, G. Rehbein, W. D. Schmitt, H.-S. Hofmann, R.-E. Silber, and A. Simm, "S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: Impairment by advanced tumour stages and neoadjuvant chemotherapy, " European Journal of Cancer, vol. 43, no. 13, pp. 1935-1943, 2007. (Pubitemid 47284868)
17. A. I. Riker, S. A. Enkemann, O. Fodstad, S. Liu, S. Ren, and C. Morris, "The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis, " BMC Medical Genomics, vol. 1, article 13, 2008.
18. F. Egberts, A. Pollex, J.-H. Egberts, K. C. Kaehler, M. Weichenthal, and A. Hauschild, "Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH, " Onkologie, vol. 31, no. 7, pp. 380-384, 2008. (Pubitemid 351967575)
19. G. M. Maelandsmo, V. A. Floørenes, T. Mellingsaetr, E. Hovig, R. S. Kerbel, and O. Fodstad, "Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignantmelanoma, " International Journal of Cancer, vol. 74, no. 4, pp. 464-469, 1997. (Pubitemid 27400171)
20. J. A. Gollob and C. J. Sciambi, "Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells, " Clinical Cancer Research, vol. 13, pp. 5219-5225, 2007. (Pubitemid 47502092)
21. R.-Y. Shyu, S.-L. Huang, and S.-Y. Jiang, "Retinoic acid increases expression of the calcium-binding protein S100P in human gastric cancer cells, " Journal of Biomedical Science, vol. 10, no. 3, pp. 313-319, 2003. (Pubitemid 36469818)
22. Y. Tsutsui, T. Nogami, M. Sano, A. Kashiwai, and K. Kato, "Induction of S-100b (ββ) protein in human teratocarcinoma cells, " Cell Differentiation, vol. 21, no. 2, pp. 137-145, 1987. (Pubitemid 17115826)
23. H.-T. Kim, G. Kong, D. DeNardo, et al., "Identification of biomarkers modulated by the rexinoid LGD1069 (Bexarotene) in human breast cells using oligonucleotide arrays, " Cancer Research, vol. 66, no. 24, pp. 12009-12018, 2006. (Pubitemid 46094215)
24. B. Richards, J. Karpilow, C. Dunn, et al., "Genetic selection for modulators of a retinoic-acid-responsive reporter in human cells, " Genetics, vol. 163, no. 3, pp. 1047-1060, 2003. (Pubitemid 36417946)